Statins and Breast Cancer Biomarkers: Evaluation of Breast Density and Serum Biomarkers in Response to Statin Administration.

Trial Profile

Statins and Breast Cancer Biomarkers: Evaluation of Breast Density and Serum Biomarkers in Response to Statin Administration.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Breast cancer
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 03 Jan 2012 Status changed from recruiting to discontinued.
    • 10 Dec 2011 Interim results presented at the 34th Annual San Antonio Breast Cancer Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top